Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study.

Niklas Frahm Michael HeckerUwe Klaus Zettl

Published in: PloS one (2019)

We found a high burden of polypharmacy in patients with RRMS. This particularly applies to more severely disabled MS patients who suffer from comorbidities.

Keyphrases

multiple sclerosis
white matter
adverse drug
risk factors
emergency department
rheumatoid arthritis
disease activity